User menu

ABCB1 1199G>A polymorphism (rs2229109) affects the transport of imatinib, nilotinib and dasatinib.

Bibliographic reference Dessilly, Géraldine ; Elens, Laure ; Panin, Nadtha ; Karmani, Linda ; Demoulin, Jean-Baptiste ; et. al. ABCB1 1199G>A polymorphism (rs2229109) affects the transport of imatinib, nilotinib and dasatinib.. In: Pharmacogenomics, Vol. 17, no. 8, p. 883-890 (2016)
Permanent URL
  1. Fardel Olivier, Lecureur Valérie, Guillouzo André, The P-glycoprotein multidrug transporter, 10.1016/s0306-3623(96)00081-x
  2. Haufroid Vincent, Genetic Polymorphisms of ATP-Binding Cassette Transporters ABCB1 and ABCC2 and their Impact on Drug Disposition, 10.2174/138945011795378487
  3. Cascorbi Ingolf, Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs, 10.1016/j.pharmthera.2006.04.009
  4. Li YH, Yi Chuan Xue Bao, 33, 93 (2006)
  5. Bodor Miklos, Kelley Edward J., Ho Rodney J., Characterization of the humanMDR1 gene, 10.1208/aapsj070101
  6. Dessilly Géraldine, Elens Laure, Panin Nadtha, Capron Arnaud, Decottignies Anabelle, Demoulin Jean-Baptiste, Haufroid Vincent, ABCB1 1199G>A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines, 10.1371/journal.pone.0091555
  7. Gregers J, Gréen H, Christensen I J, Dalhoff K, Schroeder H, Carlsen N, Rosthoej S, Lausen B, Schmiegelow K, Peterson C, Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia, 10.1038/tpj.2014.81
  8. Woodahl E. L., Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein, 10.1124/jpet.104.065383
  9. Gurney H, Wong M, Balleine R L, Rivory L P, McLachlan A J, Hoskins J M, Wilcken N, Clarke C L, Mann G J, Collins M, Delforce S-E, Lynch K, Schran H, Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype, 10.1038/sj.clpt.6100201
  10. Dohse M., Scharenberg C., Shukla S., Robey R. W., Volkmann T., Deeken J. F., Brendel C., Ambudkar S. V., Neubauer A., Bates S. E., Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib, 10.1124/dmd.109.031302
  11. Hegedűs C, Özvegy-Laczka C, Apáti Á, Magócsi M, Német K, Őrfi L, Kéri G, Katona M, Takáts Z, Váradi A, Szakács G, Sarkadi B, Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties : Interaction of Bcr-Abl inhibitors and MDR-ABC proteins, 10.1111/j.1476-5381.2009.00383.x
  12. Skoglund Karin, Boiso Moreno Samuel, Baytar Maria, Jönsson Jan Ingvar, Gréen Henrik, ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro, 10.2147/pgpm.s45522
  13. Miura Masatomo, Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients with Chronic Myeloid Leukemia, 10.1248/bpb.b15-00103
  14. Picard S., Titier K., Etienne G., Teilhet E., Ducint D., Bernard M.-A., Lassalle R., Marit G., Reiffers J., Begaud B., Moore N., Molimard M., Mahon F.-X., Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia, 10.1182/blood-2006-07-036012
  15. Capron Arnaud, Mourad Michel, De Meyer Martine, De Pauw Luc, Eddour Djamila Chaib, Latinne Dominique, Elens Laure, Haufroid Vincent, Wallemacq Pierre, CYP3A5andABCB1polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation, 10.2217/pgs.10.43
  16. Elens Laure, Capron Arnaud, Kerckhove Valérie Van, Lerut Jan, Mourad Michel, Lison Dominique, Wallemacq Pierre, Haufroid Vincent, 1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation : , 10.1097/fpc.0b013e3282e9a533
  17. Zheng Q, Wu H, Yu Q, Kim D H (Dennis), Lipton J H, Angelini S, Soverini S, Vivona D, Takahashi N, Cao J, ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis, 10.1038/tpj.2014.54
  18. Vivona Douglas, Bueno Carolina T., Lima Luciene T., Hirata Rosario D.C., Hirata Mario H., Luchessi André D., Zanichelli Maria A., Chiattone Carlos S., Guerra-Shinohara Elvira M., ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib, 10.1016/j.bcmd.2011.11.001
  19. Ma L, Onco Targets Ther., 8, 1009 (2015)
  20. Dulucq S., Bouchet S., Turcq B., Lippert E., Etienne G., Reiffers J., Molimard M., Krajinovic M., Mahon F.-X., Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia, 10.1182/blood-2008-03-147744
  21. Au Anthony, Aziz Baba Abdul, Goh Ai Sim, Wahid Fadilah S. Abdul, Teh Alan, Rosline Hassan, Ankathil Ravindran, Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients, 10.1016/j.biopha.2014.01.009